Increased levels and activity of cathepsins B and D in kainate-induced toxicity

Neuroscience

Volumn 284, Issue , 2015, Pages 360-373

  Banerjee, M ^a   Sasse, V A ^a,b   Wang, Y ^a,b   Maulik, M ^a,b   Kar, S ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cathepsins; Epilepsy; Hippocampus; Insulin like growth factor II receptor; Neurodegeneration; Seizures

Indexed keywords

CATHEPSIN B; CATHEPSIN D; CYTOCHROME C; GLIAL FIBRILLARY ACIDIC PROTEIN; KAINIC ACID; PROTEIN ANTIBODY; PROTEIN BAX; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; BAX PROTEIN, RAT; CASP3 PROTEIN, RAT; CASPASE 3; CATION-DEPENDENT MANNOSE-6-PHOSPHATE RECEPTOR; CTSB PROTEIN, RAT; CTSD PROTEIN, RAT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY LABELING; ARTICLE; ASTROCYTE; BIOAVAILABILITY; CELL FRACTIONATION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME METABOLISM; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROGLIA; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RADIOIMMUNOPRECIPITATION; RAT; SEIZURE; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECTS; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ASTROCYTES; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CATHEPSIN B; CATHEPSIN D; CYTOCHROMES C; HIPPOCAMPUS; KAINIC ACID; MALE; MICROGLIA; NEURONS; RATS, SPRAGUE-DAWLEY; RECEPTOR, IGF TYPE 2;

EID: 84908587129     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.10.003     Document Type: Article

References (80)

1. Acarin L., Villapol S., Faiz M., Rohn T.T., Castellano B., Gonzalez B. Caspase-3 activation in astrocytes following postnatal excitotoxic damage correlates with cytoskeletal remodelling but not with cell death or proliferation. Glia 2007, 55:954-965.
2. Aras R., Barron A.M., Pike C.J. Caspase activation contributes to astrogliosis. Brain Res 2012, 1450:102-115.
3. Akahoshi N., Murashima Y.L., Himi T., Ishizaki Y., Ishii I. Increased expression of the lysosomal protease cathepsin S in hippocampal microglia following kainite-induced seizures. Neurosci Lett 2007, 429:136-141.
4. Amritraj A., Peake K., Kodam A., Salio C., Merighi A., Vance J., Kar S. Increased activity and altered subcellular distribution of lysosomal enzymes determine neuronal vulnerability in Niemann Pick type C-deficient mice. Am J Pathol 2009, 175:2540-2556.
5. Amritraj A., Wang Y., Revett T.J., Vergote D., Westaway D., Kar S. Role of cathepsin D in U18666A-induced neuronal cell death: potential implication in Niemann Pick Type C disease pathogenesis. J Biol Chem 2013, 288:3136-3152.
6. Barlow C., Ribaut-Barassin C., Zwingman T.A., Pope A.J., Brown K.D., Owens J.W., Larson D., Harrington E.A., Haeberle A.M., Mariani J., Eckhaus M., Herrup K., Bailly Y., Wynshaw-Boris A. ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation. Proc Natl Acad Sci U S A 2000, 97:871-876.
7. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 1985, 14:375-403.
8. Ben-Ari Y., Tremblay E., Riche D., Ghilini G., Naquet R. Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neuroscience 1981, 6:1361-1391.
9. Ben-Ari Y., Cossart R. Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci 2000, 23:580-587.
10. Bendiske J., Bahr B.A. Lysosomal activation is a compensatory response against protein accumulation and associated synaptogenesis - an approach for slowing Alzheimer's disease ?. J Neuropathol Exp Neurol 2003, 62:451-463.
11. Benes P., Vetvicka V., Fusek M. Cathepsin D - many functions of one aspartic protease. Crit Rev Oncol Hematol 2008, 68:12-28.
12. Bengzon J., Mohapel P., Ekdahl C.T., Lindvall O. Neuronal apoptosis after brief and prolonged seizures. Prog Brain Res 2002, 135:111-119.
13. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., Volterra A. CXCR4-activated astrocytes glutamate via TNFα: amplification by microglia triggers neurotoxicity. Nat Neurosci 2001, 4:702-710.
14. Bleakman D., Lodge D. Neuropharmacology of AMPA and kainite receptors. Neuropharmacology 1998, 37:1187-1204.
15. Boya P., Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene 2008, 27:6434-6451.
16. Braulke T., Bonifacino J.S. Sorting of lysosomal proteins. Biochim Biophys Acta 2009, 1793:605-614.
17. Brown G.C., Neher J.J. Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol 2010, 41:242-247.
18. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ 2001, 8:569-581.
19. Butler D., Hwang J., Estick C., Nishiyama A., Kumar S.S., Baveghems C., Young-Oxendine H.B., Wisniewski M.L., Charalambides A., Bahr B.A. Protective effects of positive lysosomal modulation in Alzheimer's disease transgenic mouse models. PLoS One 2011, 6:e20501.
20. Byun Y., Chen F., Chang R., Trivedi M., Green K.J., Cryns V.L. Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis. Cell Death Differ 2001, 8:443-450.
21. Ceccariglia S., D'Altocolle A., Del Fa A., Pizzolante F., Caccia E., Michetti F., Gangitano C. Cathepsin D plays a crucial role in the trimethyltin-induced hippocampal neurodegeneration process. Neuroscience 2011, 174:160-170.
22. Cerbai F., Lana D., Nosi D., Petkova-Kirova P., Zecchi S., Brothers H.M., Wenk G.L., Giovannini M.G. The neuron-astrocyte-microglia triad in normal brain aging and in a model of neuroinflammation in the rat hippocampus. PLoS One 2012, 7:e45250.
23. Chwieralski C.E., Welte T., Buhling F. Cathepsin-regulated apoptosis. Apoptosis 2006, 11:143-149.
24. Cannon J.R., Tapias V., Na H.M., Honick A.S., Drolet R.E., Greenamyre J.T. A highly reproducible rotenone model of Parkinson's disease. Neurobiol Dis 2009, 34:279-290.
25. Coulter D.A., McIntyre D.C., Loscher W. Animal models of limbic epilepsies: what can they tell us?. Brain Pathol 2002, 12:240-256.
26. Dagvajantsan B., Aoki M., Warita H., Suzuki N., Itoyama Y. Up-regulation of insulin-like growth factor-II receptor in reactive astrocytes in the spinal cord of amyotrophic lateral sclerosis transgenic rats. Tohoku J Exp Med 2008, 214:303-310.
27. 2+ signals contribute to neuronal excitotoxicity after status epilepticus. J Neurosci 2007, 27:10674-10684.
28. Ditaranto K., Tekirian T.L., Yang A.J. Lysosomal membrane damage in soluble Aβ-mediated cell death in Alzheimer's disease. Neurobiol Dis 2001, 8:19-31.
29. Eid T., Williamson A., Lee T.S.W., Petroff O.A., de Lanerolle N.C. Glutamate and astrocytes - key players in human mesial temporal lobe epilepsy?. Epilepsia 2008, 49(Suppl. 2):42-52.
30. German D.C., Liang C.L., Song T., Yazdani U., Xie C., Dietschy J.M. Neurodegeneration in the Niemann Pick C mouse: glial involvement. Neuroscience 2002, 109:437-450.
31. Gowran A., Campbell V.A. A role for p53 in the regulation of lysosomal permeability by delta 9-tetrahydrocannabinol in rat cortical neurons: implications for neurodegeneration. J Neurochem 2008, 105:1513-1524.
32. Hawkes C., Kar S. The insulin-like growth factor-II/mannose-6-phosphate receptor: structure, distribution and function in the central nervous system. Brain Res Rev 2004, 44:117-140.
33. Hawkes C., Kabogo D., Amritraj A., Kar S. Up-regulation of cation-independent mannose 6-phosphate receptor and endosomal-lysosomal markers in surviving neurons following 192 IgG-saporin administrations into the adult rat brain. Am J Pathol 2006, 169:1140-1154.
34. Heneka M.T., Rodriguez J.J., Verkhratsky A. Neuroglia in neurodegeneration. Brain Res Rev 2010, 63:189-211.
35. Hetman M., Filipkowski R.K., Domagala W., Kaczmarek L. Elevated cathepsin D expression in kainite-evoked rat brain neurodegeneration. Exp Neurol 1995, 136:53-63.
36. Hopkins K.J., Wang G., Schmued L.C. Temporal progression of kainic acid induced neuronal and myelin degeneration in the rat forebrain. Brain Res 2000, 864:69-80.
37. Jaattela M., Cande C., Kroemer G. Lysosomes and mitochondria in the commitment to apoptosis: a potential role for cathepsin and AIF. Cell Death Differ 2004, 11:135-136.
38. Jabs R., Seifert G., Steinhauser C. Astrocytic function and its alteration in the epileptic brain. Epilepsia 2008, 49(Suppl. 2):3-12.
39. Joensuu T., Kuronen M., Alakurtti K., Tegelberg S., Hakala P., Aalto A., Huopaniemi L., Aula N., Michellucci R., Eriksson K., Lehesjoki A.E. Cystatin B: mutation detection, alternative splicing and expression in progressive myoclonus epilepsy of Unverricht-Lundborg type (EPM1) patients. Eur J Hum Genet 2007, 15:185-193.
40. Johansson A.C., Steen H., Ollinger K., Roberg K. Cathepsin D mediates cytochrome c release and caspase activation in human fibroblast apoptosis induced by staurosporine. Cell Death Differ 2003, 10:1253-1259.
41. 125I]insulin receptor binding sites in adult rat hippocampal formation. Neuroscience 1997, 80:1041-1055.
42. Kelsey J.E., Sanderson K.L., Frye C.A. Perforant path stimulation in rats produces seizures, loss of hippocampal neurons, and a deficit in spatial mapping which are reduced by prior MK-801. Behav Brain Res 2000, 107:59-69.
43. Kodam A., Vetrivel K.S., Thinakaran G., Kar S. Cellular distribution of gamma-secretase subunit nicastrin in the developing and adult rat brains. Neurobiol Aging 2008, 29:724-738.
44. Kuranaga E., Miura M. Nonapoptotic functions of caspases: caspases as regulatory molecules for immunity and cell-fate determination. Trends Cell Biol 2007, 17:135-144.
45. Li Y., Xu C., Schubert D. The up-regulation of endosomal-lysosomal components in amyloid beta-resistant cells. J Neurochem 1999, 73:1477-1482.
46. Lothman E.W., Collins R.C. Kainic acid induced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res 1981, 218:299-318.
47. Mattson M.P. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromol Med 2003, 3:65-94.
48. Matus A., Green G.D. Age-related increase in a cathepsin D like protease that degrades brain microtubule-associated proteins. Biochemistry 1987, 26:8083-8086.
49. Maulik M., Ghoshal B., Kim J., Wang Y., Yang J., Westaway D., Kar S. Mutant human APP exacerbates pathology in a mouse model of NPC and its reversal by a β-cyclodextrin. Hum Mol Genet 2012, 21:4857-4875.
50. Minarowska A., Gacko M., Karwowska A., Minarowski L. Human cathepsin D. Folia Histochem Cytobiol 2008, 46:23-38.
51. Mouser P.E., Head E., Ha K.H., Rohn T.T. Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer's disease brain. Am J Pathol 2006, 168:936-946.
52. Mullins C., Bonifacino J.S. The molecular machinery for lysosomes biogenesis. Bioessays 2001, 23:333-343.
53. Nadler J.V., Perry B.W., Cotman C.W. Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature 1978, 271:676-677.
54. Nakanishi H. Neuronal and microglial cathepsins in aging and age-related diseases. Aging Res Rev 2003, 2:367-381.
55. Narkilahti S., Pirttila T.J., Lukasiuk K., Tuunanen J., Pitkanen A. Expression and activation of caspase 3 following status epilepticus in the rat. Eur J Neurosci 2003, 18:1486-1496.
56. Ni H., Yan J., Zhang L., Feng X., Wu X. Long-term effects of recurrent neonatal seizures on neurobehavioral function and related gene expression and its intervention by inhibitor of cathepsin B. Neurochem Res 2012, 37:31-39.
57. O'Dell C.M., Das A., Wallace G., Ray S.K., Banik N.L. Understanding the basic mechanisms underlying seizures in mesial temporal lobe epilepsy and possible therapeutic targets: a review. J Neurosci Res 2012, 90:913-924.
58. O'Gorman D.B., Weiss J., Hettiaratchi A., Firth S.M., Scott C.D. Insulin-like growth factor-II/mannose 6-phosphate receptor overexpression reduces growth of choriocarcinoma cells in vitro and in vivo. Endocrinology 2002, 143:4287-4294.
59. Olney J.W., Collins R.C., Sloviter R.S. Excitotoxic mechanism of epileptic brain damage. Advances in neurology 1986, 857-877. Raven Press, New York. A.V. Delgado-Escueta, A.A. Ward, D.M. Woodbury, R.J. Porter (Eds.).
60. Roberg K., Ollinger K. Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. Am J Pathol 1998, 152:1151-1156.
61. Sarkisian M.R. Overview of the current animal models for human seizure and epileptic disorders. Epilepsy Behav 2001, 2:201-216.
62. Schmued L.C., Albertson C., Slikker W. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res 1997, 751:37-46.
63. Schwob J.E., Fuller T., Price J.L., Olney J.W. Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study. Neurosceince 1980, 5:991-1014.
64. Sperk G., Lassmann H., Baran H., Kish S.J., Seitelberger F., Hornykiewicz O. Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience 1983, 10:1301-1315.
65. Tofighi R., Johansson C., Goldoni M., Ibrahim W.N., Gogvadze V., Mutti A., Ceccatelli S. Hippocampal neurons exposed to the environmental contaminants methylmercury and polychlorinated biphenyls undergo cell death via parallel activation of calpains and lysosomal proteases. Neurotox Res 2011, 19:183-194.
66. Tominaga K., Nakanishi H., Yasuda Y., Yamamoto K. Excitotoxin-induced neuronal death is associated with response of a unique intracellular aspartic proteinase, cathepsin E. J Neurochem 1998, 71:2574-2584.
67. Turk B., Stoka V., Rozman-Pungercar J., Cirman T., Droga-Mazovec G., Oresic K., Turk V. Apoptotic pathways: involvement of lysosomal proteases. Biol Chem 2002, 383:1035-1044.
68. Turk B., Turk D., Turk V. Lysosomal cysteine proteases: more than scavengers. Biochim Biophys Acta 2000, 1477:98-111.
69. Umeda T., Tomiyama T., Sakama N., Tanaka S., Lambert M.P., Klein W.L., Mori H. Intraneuronal amyloid β oligomeric cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo. J Neurosci Res 2011, 89:1031-1042.
70. Vene R., Arena G., Poggi A., D'Arrigo C., Mormino M., Noonan D.M., Albini A., Tosetti F. Novel cell death pathways induced by N-(4-hydroxyphenyl)retinamide: therapeutic implications. Mol Cancer Ther 2007, 6:286-298.
71. Vincent P., Mulle C. Kainate receptors in epilepsy and excitotoxicity. Neuroscience 2009, 158:309-323.
72. Vitner E.B., Dekel H., Zigdon H., Shachar T., Farfel-Becker T., Eilam R., Karlsson S., Futerman A.H. Altered expression and distribution of cathepsins in neuronopathic forms of Gaucher disease and in other sphingolipidoses. Hum Mol Genet 2010, 19:3583-3590.
73. Wagner D.C., Riegelsberger U.M., Michalk S., Hartig W., Kranz A., Boltze J. Cleaved caspase-3 expression after experimental stroke exhibits different phenotypes and its predominantly non-apoptotic. Brain Res 2011, 1381:237-242.
74. Wang Y., Gu Z., Cao Y., Liang Z., Han R., Bennett M.C., Qin Z. Lysosomal enzyme cathepsin B is involved in kainic acid-induced excitotoxicity in rat striatum. Brain Res 2006, 1071:245-249.
75. Wang Y., Han R., Liang Z.-Q., Wu J.-C., Zhang X.-D., Gu Z.-L., Qin Z.-H. An autophagic mechanism is involved in apoptotic death of art striatal neurons induced by the non-N-methyl-d-aspartate receptor agonist kainic acid. Autophagy 2008, 4:214-226.
76. Wang Q., Yu S., Simonyi A., Sun G.Y., Sun A.Y. Kainic acid-mediated excitotoxicity as a model of neurodegeneration. Mol Neurobiol 2005, 31:3-16.
77. Yamashima T., Kohda Y., Tsuchiya K., Ueno T., Yamashita J., Yoshioka T., Kominami E. Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on 'calpain-cathepsin hypothesis'. Eur J Neurosci 1998, 10:1723-1733.
78. Yang A.J., Chandswangbhuvana D., Margol L., Glabe C.G. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Aβ1-42 pathogenesis. J Neurosci Res 1998, 52:691-698.
79. Zaidi N., Maurer A., Nieke S., Kalbacher H. Cathepsin D: a cellular map. Biochem Biophys Res Commun 2008, 376:5-9.
80. Zhou G., Roizman B. Cation-independent mannose 6-phosphate receptor blocks apoptosis induced by Herpes simplex virus 1 mutants lacking glycoprotein D and is likely the target of antiapoptotic activity of the glycoprotein. J Virol 2002, 76:6197-6204.